Vapocoolant spray vs placebo spray/no treatment for reducing pain from intravenous cannulation: A meta-analysis of randomized controlled trials
The American Journal of Emergency Medicine | Apr 01, 2018
Zhu Y, et al. - Researchers compared the effectiveness of vapocoolant spray and placebo spray/no treatment for pain reduction during intravenous cannulation in this meta-analysis. Findings suggested a significant reduction in pain during intravenous cannulation with vapocoolant spray when compared with placebo spray or no treatment in both adults and children. Furthermore, vapocoolant spray was observed significantly increasing the technical ease of the attempt and participants' satisfaction. The use of vapocoolant spray during intravenous cannulation was thus recommended to decrease pain.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries